Risk Factors For Defibrillation Testing Failure In Patients With Transvenous Implantable Cardioverter Defibrillator

被引：0
|
作者：
Nakano, Makoto
Aizawa, Kentaro
Hasebe, Yuhi
Morosawa, Susumu
Hayashi, Hideka
Shimokawa, Hiroaki
机构：
来源：
CIRCULATION | 2019年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16566
引用
收藏
页数：2
相关论文
共 50 条
  • [31] RISK FACTORS FOR APPROPRIATE CARDIOVERTER-DEFIBRILLATOR SHOCKS, INAPPROPRIATE CARDIOVERTER-DEFIBRILLATOR SHOCKS, AND MORTALITY IN 549 PATIENTS WITH HEART FAILURE AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
    Aronow, Wilbert S.
    Desai, Harit
    Gandhi, Kaushang
    Ahn, Chul
    Hussain, Sadaf
    Lai, Hoang M.
    Sharma, Mala
    Frishman, William H.
    Cohen, Martin
    Sorbera, Carmine
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [32] RISK FACTORS FOR IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR LEAD FAILURE IN CHILDREN AND YOUNG ADULTS
    Janson, Christopher M.
    Patel, Akash
    Shah, Maully
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E283 - E283
  • [33] Effect of Substance Abuse on Defibrillation Threshold in Patients with Implantable Cardioverter-Defibrillator
    Perrine, Shane A.
    Nayak, Raghavendra
    Bharadwaj, Aditya S.
    Mckelvey, George
    Mohamad, Tamam
    Jacob, Sony
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2011, 34 (02): : 193 - 199
  • [34] Successful extravascular implantable cardioverter-defibrillator implantation in a patient with recurrent transvenous implantable cardioverter-defibrillator erosion
    Robinson, Andrea
    Billakanty, Sreedhar
    Fu, Eugene
    Amin, Anish
    HEART RHYTHM O2, 2024, 5 (04): : 243 - 245
  • [35] Complications of Implantable Cardioverter Defibrillator and Their Potential Risk Factors in Patients with Hypertrophic Cardiomyopathy
    Goudarzi, Mohammad Taghi Hedayati
    Moradi, Maryam
    Abrotan, Saeed
    Saravi, Mehrdad
    Shirafkan, Hoda
    Irilouzadian, Rana
    Omran, Hossein Salehi
    CARDIOLOGY RESEARCH AND PRACTICE, 2023, 2023
  • [36] Is Defibrillation Testing Necessary for Implantable Transvenous Defibrillators?
    Russo, Andrea M.
    Chung, Mina K.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2014, 7 (02): : 337 - 346
  • [37] SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR PLACEMENT IN A PATIENT WITH A PREEXISTING TRANSVENOUS ICD: A CASE FOR DEFIBRILLATOR THRESHOLD TESTING?
    Jazayeri, Mohammad-Ali
    Bartos, Joann
    Tabbert, Ted
    Jazayeri, Mohammad-Reza
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 2297 - 2297
  • [38] Isolated left ventricular diastolic dysfunction immediately after defibrillation threshold testing in patients with implantable cardioverter defibrillator
    Horigome, Miki
    Koyama, Jun
    Horigome, Mitsuaki
    Aizawa, Kazunori
    Kasai, Hiroki
    Tomita, Takeshi
    Kumazaki, Setsuo
    Tsutsui, Hiroshi
    Yazaki, Yoshikazu
    Kinoshita, Osamu
    Ikeda, Uichi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 144A - 144A
  • [39] Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter-defibrillator to confirm appropriate ventricular fibrillation detection
    de Waroux, Jean-Benoit le Polain
    Ploux, Sylvain
    Mondoly, Pierre
    Eschalier, Romain
    Strik, Marc
    Houard, Laura
    Pierre, Bertrand
    Buliard, Samuel
    Klotz, Nicolas
    Ritter, Philippe
    Haissaguerre, Michel
    Mahfouz, Karim
    Bordachar, Pierre
    HEART RHYTHM, 2018, 15 (05) : 642 - 650
  • [40] INFECTIVE ENDOCARDITIS OF THE TRANSVENOUS LEAD OF AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    WERNER, GS
    GONSKA, BD
    HERSE, B
    KREUZER, H
    ZEITSCHRIFT FUR KARDIOLOGIE, 1995, 84 (01): : 51 - 54
12345